Skip to content

Surgery alone

PROCEDURE13 trials

Sponsors

Taiho Pharmaceutical Co., Ltd., University Health Network, Toronto, Catrine Isehed, North Tees and Hartlepool NHS Foundation Trust, Tata Memorial Hospital

Conditions

Bacterial InfectionsBleeding of Subgingival SpaceBreast CancerCancerColorectal CancerFailure of Dental Implant Due to InfectionGastric CancerHCC - Hepatocellular Carcinoma

Phase 2

Phase 3

Phase 4

Unknown Phase

Femoral Bone Metastases
Active, not recruitingNCT01428895
University Health Network, TorontoCancer, Metastatic Malignant Neoplasm to Femur, Risk of Fracture
Start: 2009-03-01End: 2027-02-01Target: 180Updated: 2026-03-06
Investigating the Use of Drains and (Internal) Quilting Sutures on Seroma Formation Following Mastectomy
NCT02668263
North Tees and Hartlepool NHS Foundation TrustBreast Cancer
Start: 2015-11-30End: 2016-11-30Target: 120Updated: 2016-01-29
To Study the Impact of Radiation Treatment After Surgery in Patient With Locally Advanced Thyroid Cancer.
Active, not recruitingNCT03669432
Tata Memorial HospitalRadiation Toxicity, Thyroid Cancer Stage IV
Start: 2013-07-31End: 2026-07-31Updated: 2022-05-02
Neo-TACE-HAIC for PVTT-HCC
NCT04181931
Sun Yat-sen UniversityHepatocellular Carcinoma, Portal Vein Thrombosis
Start: 2019-12-16End: 2024-12-30Target: 320Updated: 2020-10-26
Neo-TACE-HAIC for BCLC B Stage HCC
NCT04424043
Sun Yat-sen UniversityHepatocellular Carcinoma
Start: 2020-07-08End: 2025-12-30Target: 280Updated: 2020-10-26
Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)
RecruitingNCT04777942
Sun Yat-sen UniversityHepatocellular Carcinoma
Start: 2021-02-20End: 2026-12-30Target: 320Updated: 2021-03-02
Preventing Recurrences of Chronic Subdural Hematoma in Adult Patients by Middle Meningeal Artery Embolization
RecruitingNCT05327933
Unfallkrankenhaus BerlinHematoma, Subdural, Chronic
Start: 2022-05-26End: 2025-10-31Target: 154Updated: 2025-03-30
Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2)
Not yet recruitingNCT07383142
Shanghai Zhongshan HospitalThymic Epithelial Tumor
Start: 2026-02-01End: 2032-02-01Target: 202Updated: 2026-02-06
A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors
Not yet recruitingNCT07618546
Henan Cancer HospitalHCC - Hepatocellular Carcinoma
Start: 2026-05-25End: 2028-03-31Target: 208Updated: 2026-06-01

Related Papers